Home > PE Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of TORRENT PHARMACEUTICALS is 57.00.

Share Price ₹3,218.9Jun 10,2025
Market Cap ₹108,927.6 Cr
Earnings-TTM₹1,911.0 CrTTM-Consolidated Results
Price/Earnings57.00xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of TORRENT PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹108,927.6 Cr] as on Jun 10,2025

(/) Earnings [ ₹1,911.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 57.00x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay 57.00 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of TORRENT PHARMACEUTICALS


PE Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/e ratio is 57.00x.

- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 31.77x.

- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 30.45x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 53.15x.

- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 16.28x.


How does TORRENT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
TORRENT PHARMACEUTICALS 1,911.0057.00108,927.6
SUN PHARMACEUTICAL INDUSTRIES LTD10,980.1036.89405,068.0
DIVIS LABORATORIES LTD2,191.0080.83177,105.0
CIPLA LTD5,291.0523.06122,016.0
DR REDDYS LABORATORIES LTD5,703.5019.75112,651.0
MANKIND PHARMA LTD2,003.2248.9998,130.4
ZYDUS LIFESCIENCES LTD4,614.8021.4098,771.9
LUPIN LTD3,306.2627.7291,633.7
AUROBINDO PHARMA LTD3,515.2619.3467,988.6
ABBOTT INDIA LTD1,414.4447.5567,252.2
ALKEM LABORATORIES LTD2,216.0026.7659,293.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TORRENT PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.34x
Max industry PE 80.83x
Median industry PE 27.72x
Average industry PE 37.21x



You may also like the below Video Courses